Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Swimming in the future already: the use of AI in zebrafish neurobehavioral research and CNS drug screening.

Neuroscience·2026
Same author

Intranasal Immunization with Recombinant Hemagglutinin of Influenza A/H5 Virus Complexed with Novochizol Induces Virus-Neutralizing Antibodies and Protects Animals from Lethal Viral Challenge.

Pharmaceutics·2026
Same author

Behavioral test batteries in zebrafish: methodological variability, experimental design, and implications for neurobehavioral research.

Reviews in the neurosciences·2026
Same author

Opioidergic modulation of stress-induced hyperalgesia in adult zebrafish.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Global Landscape of Zebrafish Research (2000-2025): A Bibliometric Analysis of Publication Trends, Collaboration, and Thematic Evolution.

Zebrafish·2026
Same author

Bicyclic monoterpenoid-based orthopoxvirus inhibitors: design, synthesis, and biological assessment of a novel amide series.

RSC medicinal chemistry·2026

Related Experiment Video

Updated: Jun 27, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.7K

MPTP-Treated Zebrafish Recapitulate 'Late-Stage' Parkinson's-like Cognitive Decline.

Alim A O Bashirzade1,2, Sergey V Cheresiz1,2, Alisa S Belova1,2

  • 1Scientific Research Institute of Neuroscience and Medicine, 630090 Novosibirsk, Russia.

Toxics
|February 24, 2022
PubMed
Summary

This study shows that 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in zebrafish impairs spatial working memory, modeling Parkinson's disease (PD) cognitive deficits. AI analysis revealed distinct swimming patterns in MPTP-treated zebrafish.

Keywords:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Parkinson’s diseaseartificial intelligenceinhibitory avoidance taskspontaneous alternationzebrafish

More Related Videos

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.2K
Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model
07:32

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Published on: December 28, 2021

4.1K

Related Experiment Videos

Last Updated: Jun 27, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.7K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.2K
Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model
07:32

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Published on: December 28, 2021

4.1K

Area of Science:

  • Neuroscience
  • Toxicology
  • Animal Models

Background:

  • Zebrafish are valuable models for neurotoxicology and drug screening.
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is used to model Parkinson's disease (PD) by inducing dopaminergic neuron degeneration.
  • Cognitive deficits in MPTP-induced PD models are not well understood.

Purpose of the Study:

  • To establish MPTP toxicity parameters in adult zebrafish.
  • To investigate cognitive phenotypes in an MPTP-induced zebrafish PD model.
  • To utilize artificial intelligence (AI) for unbiased behavioral analysis of MPTP effects.

Main Methods:

  • Determined the LD50 for intraperitoneal MPTP administration in adult zebrafish.
  • Assessed spatial working memory using the Y-maze test in MPTP-treated zebrafish.
  • Applied AI-based pattern recognition to analyze zebrafish swimming behavior during the Y-maze test.

Main Results:

  • Established an LD50 of 292 mg/kg for MPTP in adult zebrafish.
  • MPTP treatment (200 µg) resulted in impaired spatial working memory, indicated by poorer spontaneous alternation.
  • AI analysis identified distinct swimming behavior clusters for MPTP-treated groups, differentiating them from controls.

Conclusions:

  • MPTP treatment in adult zebrafish effectively models late-stage Parkinson's disease with observable cognitive impairments.
  • AI-driven behavioral analysis provides objective and sensitive detection of MPTP-induced neurological changes.
  • This zebrafish model offers a valuable platform for studying PD-related cognitive dysfunction and testing therapeutic interventions.